The study is a dose-escalation, open-label, multiple-dose trial to evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.
Revlimid is indicated as a treatment for multiple myeloma and anemia due to myelodysplastic syndrome linked with a deletion in the long arm of the fifth chromosome. In
Under the deal, the product will be marketed under Lodrane brand name by Hi-Tech’s branded sales and marketing company, ECR. Hi-Tech specializes in difficult to manufacture liquid and
The grant will support continued preclinical research on microRNA targeting in cardiovascular disease and help to establish a novel model system of chronic heart failure. The research aims
The company expects to conclude the Phase II trials in early next year. Lightlake intends to conduct Phase III trial at Imperial College London and other international institutions.
The results of the studies showed that the company’s RSV vaccine induces protective immunity in mice without eliciting the enhanced respiratory disease that has caused other RSV vaccine
The trial evaluated patients with locally advanced or metastatic breast cancer who had received one prior chemotherapy regimen were treated with weekly bavituximab and docetaxel. In a separate
The company has earned gross profit of $172.62m, compared to gross profit of $178.51m, for the same period last year. Hikma’s operating profit for the first quarter ended
The IND was filed by D-Pharm’s co-development partner in South Korea, Yungjin Pharmaceutical (YJP). YJP gets license to develop, register and market DP-b99 from D-Pharm in South Korea
Botox is indicated as a treatment for urinary incontinence due to detrusor overactivity linked with a neurologic condition like, SCI, MS in adults patients who have an inadequate
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.